Consent forms for oncology trials [3] (multiple letters)

New England Journal of Medicine

Volumn 348, Issue 15, 2003, Pages 1496-1497

  Geyer, Stanley J ^a   Menikoff, Jerry ^b   Grady, Christine ^c   Emanuel, Ezekiel J ^c   Horng, Sam ^c  

^a WESTERN PENNSYLVANIA HOSPITAL   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB;

CANCER RESEARCH; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; DOCUMENTATION; HUMAN; INFORMED CONSENT; LETTER; METHODOLOGY; ONCOLOGY; PRIORITY JOURNAL; BIOMEDICAL AND BEHAVIORAL RESEARCH; HEALTH CARE ORGANIZATION; NOTE; PHASE 1 CLINICAL TRIAL; STANDARD; UNITED STATES;

CLINICAL TRIALS; HUMAN; INFORMED CONSENT; MEDICAL ONCOLOGY; CLINICAL TRIALS, PHASE I; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); UNITED STATES;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

EID: 0037431354     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200304103481516     Document Type: Letter

References (0)